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The 62nd Annual Montagna Symposium
on the Biology of Skin, ‘‘Light and Skin:
How Light Sustains, Damages, Treats,
Images and Modifies Skin Biology,’’ was
held from October 10 to 14, 2013, in
Stevenson, Washington. Life and skin
evolved under sunlight; dermatology will
forever be entwined with photomedicine.
We routinely use microscopy, optical
diagnostics, phototherapy, photodynamic
therapy, and lasers while dealing with
melanoma, non-melanoma skin cancer,
photosensitivity disorders, and photo-
aging. Moreover, there are misunderstand-
ings, recent surprises, mysteries, and chal-
lenges. How do the protean cutaneous
and systemic effects of light really hap-
pen? Exactly what is healthy and
unhealthy about light? Can these effects
be separated? What is the ideal sunsc-
reen? What can we ‘‘see’’ inside live
skin? Which technologies are pushing
the limits for therapy and diagnosis?
How to ‘‘translate’’ promising research all
the way to practical impact? The Sympo-
sium was organized by Molly Kulesz-
Martin and chaired by Rox Anderson
with Session Chairs David Fisher, Barbara
A. Gilchrest, and Steven Jacques.
The meeting started (and ended) with
provocative talks by British dermatologist-
scientists. Antony Young delivered the
keynote address, ‘‘Impact of Climate
Change on Skin,’’ describing the first
large prospective database regarding
human behavior, sun exposure, sunsc-
reen use, and biomarkers for UV expo-
sure. He reported large prospective,
collaborative studies measuring solar UV
exposure, hydroxy-vitamin D3 levels, and
biomarkers of DNA damage and repair in
‘‘free-ranging’’ Europeans at home and on
holiday. The subjects kept detailed logs of
their activities and sunscreen use, wore a
watch-like monitor of solar UV exposure,
and provided blood and urine samples.
Sun exposure was highly correlated with
thymidine dimer products in the urine
and significantly correlated with circulat-
ing 25-hydroxy-vitamin D3 levels, and
both were decreased with sunscreen use.
Surprisingly, the slope of the solar expo-
sure–vitamin D3 dose-response curve
was independent of skin pigmentation,
suggesting that substantial vitamin D3
photochemistry occurs in the upper epi-
dermis above the heavily pigmented
basal cell layer.
Session Chair David Fisher presented
the molecular, cell, and skin biology
underlying pigmentation and melanoma.
The UV-induced melanogenesis cascade
includes keratinocyte synthesis of pro-
opiomelanocortin macropeptide, which is
cleaved to produce both MSH (melano-
cyte-stimulating hormones) and endo-
rphins. Mice (much like Young’s
Europeans) become addicted to UV expo-
sure and actively choose it, a preference
that was suppressed when endorphin
receptors were blocked by naloxone.
Why has a systemic system for sun-seeking
behavior evolved, with skin at its center?
Melanocortin receptor (MC1R) sequence
polymorphisms that ablate function lead to
red hair and increased susceptibility to
UV-induced skin cancers. In mice, forsko-
lin, a cAMP agonist, bypasses the MC1R
defect and leads to the production of
eumelanin. Potentially, phosphodiesterase
PDE4D3 inhibitors that increase cAMP
levels in humans could reduce melanoma
risk in redheads. But how does MC1R
deficiency increase skin cancer risk? Mice
lacking pheomelanin (deficient in both
MC1R and tyrosinase) are less susceptible,
strongly suggesting that pheomelanin
per se enhances UV-independent and UV-
induced skin cancers. Furthermore, increa-
sed DNA oxidation products were found
without any UV exposure in the red-haired
mice. These results from the Fisher lab
suggest that pheomelanin elevates produc-
tion of reactive oxygen species, which can
drive UV-induced mutations and skin
cancer, and that antioxidant protection
strategies may work best in redheads.
Emi Nishimura reported that targeting
c-kit produces temporary graying of hair
in mice, without loss of follicular mela-
nocytes. In contrast, aging decreases and
eventually depletes the melanocyte stem
cells (MSCs) in the bulge region of hair
follicles, after which the hair remains
permanently white. Mutation and/or
genetic instability appears to have a
central role in this. Aging and X-ray
exposure are associated with increased
expression of gH2AX, a DNA damage
marker, in MSCs of the hair follicle
bulge. Nishimura hypothesized that
follicular MSCs may have unusual sus-
ceptibility to ionizing radiation damage,
and subsequently found that activated
MSCs are less sensitive to X-ray than
nonactivated MSCs. The mechanisms
involved may shed light on hair graying,
including its prevention and reversal.
Andrew Borkowski reported mechanisms
by which damage-associated molecular
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pathways (DAMPs), in particular small
noncoding RNAs, are important for skin-
barrier maintenance. Toll-like receptor 3
(TRL3) is a target for DAMPs. Inhibition
of TLR3 caused transient profound
decrease of skin-barrier response genes.
In particular, UVB exposure damages
the skin barrier and stimulates a robust
epidermal barrier repair res-
ponse. Richard Gallo further discussed
the role of DAMPs in mediating
UV-induced immunosuppression and
apoptosis. Keratinocytes not exposed to
UV but to media from UV-exposed cells
exhibit a bystander injury response,
which can be blocked by addition of
RNAse or TLR3 inhibitors. Gallo noted
that the skin-commensal bacterium
S. epidermidis partially inhibits some
TLR3-mediated responses, presumably
conferring tolerance and perhaps some
abrogation of UV responses. Could TLR3
inhibitors treat certain photosensitivity
diseases—such as lupus erythematosus—
with DAMP-mediated pathophysiology?
UV- and light-induced genotoxicity
occurs from multiple mechanisms,
including primary DNA photochemistry,
oxidative photoproducts, delayed
damage from endogenous response
pathways, and faulty repair. Sergiy
Kyryachenko introduced the topic of
keratinocyte-derived factors, such as
alpha-melanocyte-stimulating hormone-
sand endothelin, in promoting mela-
noma, and Arup Indra discussed RXR
retinoid receptors in modulating innate
immunity and cell survival after UV
exposure. Sancy Leachman discussed
the complex mechanisms and action
spectrum for UV-induced genotoxicity,
with emphasis on oxidative damage.
Nrf-2 is part of a MC1R-mediated path-
way that regulates antioxidant genes. In
MC1R-deficient mice, Nrf-2 is inactive
and antioxidant gene expression is
reduced. Leachman reported a series of
studies showing that sulforaphane, an
antioxidant contained in broccoli
sprouts, restores Nrf-2 activity through
interaction with a protein called Keap-1.
Session Chair Barbara Gilchrest spoke
about the presumptive role of telomeres
in UV responses. She noted that the
disruption of the telomere loop experi-
mentally can initiate DNA damage–like
signaling, resulting in cell senescence
(permanent inability to divide) or
apoptosis depending on the cell type.
Because telomeres in all mammalian
species are tandem repeats of TTAGGG
and its complement, the telomere is an
excellent target for DNA damage: thy-
midine dinucleotides, the substrate for
perhaps 70% of UVB damage; and
guanine, the target for oxidative DNA
damage and major target for UVA irra-
diation. The extensive damage intro-
duced during UV irradiation or the
influx of repair proteins might therefore
disrupt the telomere loop, leading to
DNA damage signaling that, if suffi-
ciently severe, would result in cell
senescence and apoptosis in the skin,
consistent with photoaging, or if less
severe to p53-mediated protective
responses such as the well-documented
enhanced melanogenesis (tanning) and
the upregulation of DNA repair capa-
city. As further support for a central role
of telomeres in cellular response to UV,
identical responses can be induced
by treatment of cells or intact skin with
telomere homolog oligonucleotides that
interact with telomeric DNA to activate
the identical signaling pathway.
Craig Elmets discussed the role of
cyclooxygenase (COX) genes in mediat-
ing UV-induced skin cancer. UV induces
COX-2 and downstream prostaglandin
E2, a major inflammatory cytokine. In
mice, knocking out COX-2 or administer-
ing the selective inhibitor celecoxib signi-
ficantly reduces UV-induced skin cancer.
In a randomized controlled clinical trial of
celecoxib in 4200 skin cancer–prone
subjects, there was no significant reduc-
tion in actinic keratosis, but non-mela-
noma skin cancers were significantly
reduced by more than 50%. Topical
COX-2 inhibitors could possibly be devel-
oped for skin cancer reduction in organ
transplant recipients.
Which proteases have a role in
photoaging? Thomas Ruenger reported
that solar elastosis involves cathepsin K,
a lysosomal enzyme that is debatably
the most potent of human collagenases.
Cathepsin K knockout mice exhibit
hypertrophic scarring. Cathepsin K also
processes elastin, which accumulates in
photoaged dermis. In fibroblasts from
young individuals, but not old indivi-
duals, cathepsin K was induced by UVA
(not UVB). Other disorders exist in
which abnormal extracellular proteins
accumulate during aging due to the
failure of lysosome functioning as cha-
perone protein-mediated autophagy
decreases. In the Hutchinson Gilford
progeria syndrome, a protein called
progerin accumulates. Runger reported
that UVA (again, not UVB) induced
accumulation of progerin in normal skin
fibroblasts, along with cell nuclear
changes similar to Hutchinson Gilford
progeria syndrome. Preventive strategies
may emerge from this research.
A promising new tool for evaluating
the pathogenesis of various types of skin
inflammation was presented by Phillip
Tong. He described a cutaneous
‘‘immune atlas’’ created by using intravital
multiphoton microscopy (MPM) to visua-
lize fluorescently tagged immune popula-
tions in reporter mice. He showed three-
dimensional imaging of immune cells
infiltrating living mouse skin, and quanti-
fied macrophages, dermal dendritic cells,
mast cells, and T cells in defined locations
in the skin at multiple body sites.
Session Chair Steven Jacques led a tour
through imaging technologies introducing
a superb session on optical imaging,
microscopy, and spectroscopy. He
explained the energy source and wave-
length-dependent ability to use light in
order to probe tissue structure on the
nano-, micro-, and meso-scales. In parti-
cular, second-harmonic-generation ima-
ging nanoscale sensing (1–10nm) and its
dependence on asymmetrical structure
was explained. Light scattering as a con-
trast mechanism, offering macroscale sen-
sing (50–10mm), was discussed with
examples of monitoring collagen fibrils
transition to larger collagen fiber bundles.
The intrinsic optical absorption and
scattering properties of skin can be deter-
mined from external measurements.
Anthony Durkin is using spatial light
modulation over a range of wavelengths
to noninvasively map the oxygen satura-
tion of cutaneous blood. He found that the
detection of cutaneous burn injury depth
was successful in a swine model, even for
burns deeper than the eye could see.
In vivo microscopy is painless and
harmless, and yields images immediately
without artifacts, but lacks the advantage
of specific tissue staining. Haishan Zeng
presented impressive images of skin by
coregistering reflectance confocal micro-
scopy (RCM), MPM, and Raman
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spectroscopy (RS). RCM has been in steady
use for live human skin imaging for more
than a decade. RS interrogates molecular
structure, e.g., of small metabolites, lipids,
nucleic acids, and proteins. Zeng dis-
cussed microscopes that combine RCM
for structural imaging with MPM for iden-
tification of elastin, NADH, collagen, and
other molecules, and with RS for point
determination of chemical structures.
Impressive progress of RCM toward
clinical applications was presented by
Milind Rajadhyaksha. Tumor cell nuclei
are easily seen when aluminum chloride
or acetic acid is applied as contrast
agent for about 1 minute. For basal cell
carcinoma, RCM has sensitivity of
92–100% and specificity of 88–97%.
Rajadhyaksha proposed a ‘‘real-time’’
analog of Mohs surgery, using RCM to
guide an erbium (Er) laser for tissue
removal. Imaging was possible through
the thin layer of thermal injury left by Er
laser, and a false color rendition of RCM
images was able to mimic the familiar
appearance of hematoxylin and eosin
(H&E). Daniel Gareau presented compu-
ter vision algorithms to differentiate his-
tologically identified melanomas from
benign nevi. Using a novel polar repre-
sentation of dermoscopy image metrics,
neural network training was performed
on a set of 88 lesions, which yielded 10
metrics significantly correlated with mel-
anoma. Next, in a prospective set of 60
melanomas and 60 nevi, the neural net-
work achieved 100% sensitivity and 30%
specificity, which is much better than that
expected for a commercially available
mole-imaging device.
Optical coherence tomography (OCT)
is an optical analog to ultrasound imaging,
detecting back-scattered light as a function
of depth in tissue. Blood flow modulates
the back-scattered light, and Ruikang
Wang showed remarkable images of skin
microvasculature obtained by Doppler
optical coherence tomography. Another
strategy for label-free imaging of perfusion
is speckle modulation. Speckle is an
interference pattern of back-scattered light
from coherent (laser) sources, which
moves when the light-scattering objects
move, e.g., with blood flow. Overall, this
session showed that huge strides have
been made in the imaging field, and that
these techniques are heading toward clin-
ical applications.
At the Saturday banquet, John Parrish
presented via video (now available at
www.MontagnaSymposium.org) an enter-
taining and substantial personal history of
the birth of sunscreens, PUVA, narrow-
band UVB, and dermatological lasers,
including rich stories that sparked (literally)
reminiscences of early lasers in the clinic.
The final day focused on emerging
optical therapies. Rox Anderson discussed
target-selective optical treatments, includ-
ing the use of 1720nm laser pulses pre-
ferentially absorbed by sebum lipids as a
potential treatment for acne. Another strat-
egy uses light-absorbing gold nanoshells
forced into the glands by a topical route,
followed by laser exposure. In collaborative
studies, the nanoshells were driven into
sebaceous glands by mechanical vibration
then exposed to a near infrared laser
resulting in local thermal damage to sebac-
eous glands, with clinical improvement.
Conor Evans presented outstanding 3D
images using coherent antistokes Raman
scattering of lipids in live-mouse sebaceous
glands obtained in situ without stains. After
exposing mouse ears to cold temperatures,
Evans and colleagues showed that sebo-
cytes in vivo suffer selective injury as a
result of cytoplasmic lipid crystallization.
The potential therapeutic role of ‘‘ultra-
short’’ lasers was considered. Although
there is but one picosecond laser now in
dermatological use (for tattoo removal),
there are no femtosecond (fs) lasers in
dermatology practice (for anything).
Focused fs lasers are capable of very
precise dermal cutting without thermal
damage. Tracy (Hequn) Wang discussed
the potential of fs laser pulses for skin
treatment, showing local tissue effects near
a laser focus within intact skin. A system
that simultaneously provides skin imaging
by MPM and precise cutting of the imaged
tissue appears to be feasible.
Highly effective treatment of microvas-
cular skin malformations, especially port-
wine stains (PWS), remains an elusive
goal. Evidence is growing that hypoxia
after pulsed dye laser (PDL) treatment
may induce unwanted angiogenesis.
PDL treatment of neonates less than about
3 months old is much more effective than
treatment of older children or adults with
PWS. A novel suggestion was made dur-
ing discussion that fetal hemoglobin,
which confers greater tolerance to
hypoxia, may be responsible. Studies at
the University of California, Irvine by
Kristen Kelly, Wesley Moy, and others
have shown better response when angio-
genesis inhibitors (rapamycin, imiquimod)
are administered before and after PDL
treatment. The addition of photosensitiz-
ing drugs also enhances efficacy. Wesley
Moy reported that intravenous administra-
tion of the photodynamic photosensitizer
NPe6 produces significantly greater vessel
clearance after PDL in animal studies,
whereas Dr Kelly discussed new clinical
evidence. Several photodynamic therapy
drugs have been shown to be effective for
PWS after intravenous administration and
light exposure. Laser speckle modulation
imaging was also used to monitor local
microvascular blood flow during PDL
treatment of PWS. A laser fluence-depen-
dent immediate decrease in perfusion was
observed representing microvascular
injury. However, loss of perfusion was
patchy, with reperfusion noted in some
areas that could be reduced by multiple
‘‘passes’’ of laser treatment. At present, it
remains unknown whether local perfusion
is a reliable guide during PWS treatment.
Fractional laser treatments use a narrow
laser beam to create an array of small
zones of thermal damage that heal rapidly
without scarring, stimulating a tissue remo-
deling process. Ablative fractional CO2 or
Er lasers make an array of vertical micro-
channels, extending to controllable depths
in the skin. Merete Haedersdal is using
these microchannels as conduits for topical
drug delivery. In ex vivo human skin, there
was a very large increase in the transport
of small and large hydrophilic molecules.
A study was performed comparing clinical
cure rates of actinic keratosis lesions by
PDT using topical methyl-aminolevulinic
acid and red light-emitting diode light
sources with vs. those without fractional
Er laser to assist the drug uptake. There was
a significantly greater clearance, with sig-
nificantly reduced recurrence, after frac-
tional laser-assisted drug delivery.
Considering that there are little data avail-
able about fractional laser-assisted uptake
for the host of topical medications avail-
able in dermatology, caution was advised.
A critical update on fractional laser
treatments was presented by Dieter
Manstein. Photoaging, scars, tattoos, drug-
induced pigmentation, and some pigmen-
tary disorders respond. Manstein suggested
a new strategy in which the microchannels
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created by laser ablation are used to
deliver a different laser wavelength that
would otherwise not penetrate well into
skin. He reported that a large volume of
deep dermal or even subcutaneous tissue
can be affected this way. Dr Manstein is
exploring fractional laser treatment in other
organs, i.e., fibrosis in heart and liver.
The meeting ended with something con-
troversial and something hopeful. Properly
revealed, changes in appearance motivate
people to actually use sunscreen. Trevor
Jones summarized a pilot study in which
112 adults attending a SnowSports conven-
tion were briefly shown UV camera images
of themselves that highlighted photodam-
age. More than three-fourth of the 41%
who replied 2 months later reported greater
sun avoidance and sunscreen use.
Richard Weller delivered a surprising
and controversial talk. High blood pres-
sure, the leading Disability Adjusted Life
Years risk factor for death and disability, is
correlated with latitude (r2¼0.26) and
season. Evidence is mounting that UVA
exposure of skin at solar levels decreases
blood pressure, probably through nitric
oxide (NO) pathways. Weller and collea-
gues previously reported in this journal that
UV could release NO stores in skin, inde-
pendent of NO synthetases (Mowbray
et al., 2009). An NO-activated fluorescent
imaging probe revealed that UVA releases
a dose- and time-dependent pool of NO,
primarily in the upper epidermis. UVA
exposure to subjects’ forearms produces a
local increase in cutaneous blood flow, but
a decrease in the peripheral vascular
resistance may not be the dominant
mechanism for UVA-induced decrease in
blood pressure. In 24 adults exposed to
UVA, blood pressure was lowered, along
with concomitant decreases in circulating
nitrate and increases in circulating nitrite.
A final brainstorming session was sti-
mulated by William Ju’s presentation on
how to foster and support innovative,
impactful treatments for patients with skin
conditions. There is a jagged continuum of
steps including problem definition, scien-
tific discovery, invention, investment, pro-
duct development, regulatory approval,
commercialization, access (including
affordability), and finally patient use. Our
skin research community has outstanding
diversity, scientific substrate, creativity,
and resourcefulness but is challenged to
navigate this jagged pathway.
All told, the 2013 Montagna Sympo-
sium brought together a group of skin
scientists as diverse, interactive, and
provocative as photobiology itself. This
field is poised to make major contribu-
tions and fits John Parrish’s definition of
dermatology—‘‘the skin and everything
in it.’’ Unprecedented optical diagnos-
tics are on clinical dermatology’s thresh-
old, and so are novel light therapies. I
sincerely thank the organizers, cochairs,
speakers, poster authors, sponsoring
organizations, and all who attended,
especially students and residents.
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California, San Diego; Marcus Calkins,
PhD, Oregon Health & Science Univer-
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efeller University; Jodi L. Johnson, PhD,
Northwestern University; Kivanc Kose,
PhD, Memorial Sloan-Kettering Cancer
Center; Rajan Kulkarni, MD, PhD, Uni-
versity of California, Los Angeles; Wes-
ley Moy, MS, University of California,
Irvine; Philip L. Tong, MD, Centenary
Institute, Royal Prince Albert Hospital/
University of Sydney; Tracy (Hequn)
Wang, PhD, University of Washington.
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